drugset / Trial / NCT04456504

HepB-CpG Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders

NCT04456504

Phase 4 Completed 49 enrolled University of Wisconsin, Madison
NaSingle-groupOpen-labelPrevention

Summary

This study is being done to determine if healthcare workers who have previously failed to respond to hepatitis B vaccine series will respond to a hepatitis B with CpG adjuvant (hepB-CpG) (Heplisav-B)

Timeline

Start
2020-09-15
Primary completion
2023-12-06
Completion
2023-12-06

Drugs

EvaluationDrugModalityDoseRoute
Subject HEPLISAV-B Vaccine

Indications

No indication recorded.